Literature DB >> 28587761

ITV, mid-ventilation, gating or couch tracking - A comparison of respiratory motion-management techniques based on 4D dose calculations.

Stefanie Ehrbar1, Alexander Jöhl2, Adrianna Tartas3, Luisa Sabrina Stark4, Oliver Riesterer4, Stephan Klöck4, Matthias Guckenberger4, Stephanie Tanadini-Lang4.   

Abstract

PURPOSE: Respiratory motion-management techniques (MMT) aim to ensure tumor dose coverage while sparing lung tissue. Dynamic treatment-couch tracking of the moving tumor is a promising new MMT and was compared to the internal-target-volume (ITV) concept, the mid-ventilation (MidV) principle and the gating approach in a planning study based on 4D dose calculations.
METHODS: For twenty patients with lung lesions, planning target volumes (PTV) were adapted to the MMT and stereotactic body radiotherapy treatments were prepared with the 65%-isodose enclosing the PTV. For tracking, three concepts for target volume definition were considered: Including the gross tumor volume of one phase (single-phase tracking), including deformations between phases (multi-phase tracking) and additionally including tracking latencies of a couch tracking system (reliable couch tracking). The accumulated tumor and lung doses were estimated with 4D dose calculations based on 4D-CT datasets and deformable image registration.
RESULTS: Single-phase tracking showed the lowest ipsilateral lung Dmean (median: 3.3Gy), followed by multi-phase tracking, gating, reliable couch tracking, MidV and ITV concepts (3.6, 3.8, 4.1, 4.3 and 4.8Gy). The 4D dose calculations showed the MidV and single-phase tracking overestimated the target mean dose (-2.3% and -1.3%), while it was slightly underestimated by the other MMT (<+1%).
CONCLUSION: The ITV concept ensures tumor coverage, but exposes the lung tissue to a higher dose. The MidV, gating and tracking concepts were shown to reduce the lung dose. Neglecting non-translational changes of the tumor in the target volume definition for tracking results in a slightly reduced target coverage. The slightly inferior dose coverage for MidV should be considered when applying this technique clinically.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4D dose calculation; Gating; Lung cancer; Respiratory motion management; Stereotactic body radiation therapy; Tracking

Mesh:

Year:  2017        PMID: 28587761     DOI: 10.1016/j.radonc.2017.05.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  13 in total

1.  Investigation of 4D dose in volumetric modulated arc therapy-based stereotactic body radiation therapy: does fractional dose or number of arcs matter?

Authors:  Takashi Shintani; Mitsuhiro Nakamura; Yukinori Matsuo; Yuki Miyabe; Nobutaka Mukumoto; Takamasa Mitsuyoshi; Yusuke Iizuka; Takashi Mizowaki
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

2.  Application of real-time MRI-guided linear accelerator in stereotactic ablative body radiotherapy for non-small cell lung cancer: one step forward to precise targeting.

Authors:  Hye Jin Kang; Yoo-Kang Kwak; Myungsoo Kim; So Jung Lee
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-30       Impact factor: 4.322

3.  Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison.

Authors:  Jessica Prunaretty; Pierre Boisselier; Norbert Aillères; Olivier Riou; Sebastien Simeon; Ludovic Bedos; David Azria; Pascal Fenoglietto
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-24

4.  Software simulation of tumour motion dose effects during flattened and unflattened ITV-based VMAT lung SBRT.

Authors:  Marta Adamczyk; Marta Kruszyna-Mochalska; Anna Rucińska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-11

5.  Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.

Authors:  Konstantina Karava; Stefanie Ehrbar; Oliver Riesterer; Johannes Roesch; Stefan Glatz; Stephan Klöck; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Radiat Oncol       Date:  2017-11-09       Impact factor: 3.481

6.  Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging.

Authors:  Martin J Menten; Jonathan K Mohajer; Rahul Nilawar; Jenny Bertholet; Alex Dunlop; Angela U Pathmanathan; Michel Moreau; Spencer Marshall; Andreas Wetscherek; Simeon Nill; Alison C Tree; Uwe Oelfke
Journal:  Radiother Oncol       Date:  2020-01-10       Impact factor: 6.280

7.  The ideal couch tracking system-Requirements and evaluation of current systems.

Authors:  Alexander Jöhl; Stefanie Ehrbar; Matthias Guckenberger; Stephan Klöck; Andreas Mack; Mirko Meboldt; Melanie Zeilinger; Stephanie Tanadini-Lang; Marianne Schmid Daners
Journal:  J Appl Clin Med Phys       Date:  2019-09-19       Impact factor: 2.102

8.  ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.

Authors:  J Bellec; F Arab-Ceschia; J Castelli; C Lafond; E Chajon
Journal:  Radiat Oncol       Date:  2020-03-03       Impact factor: 3.481

9.  Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.

Authors:  Makoto Sasaki; Mitsuhiro Nakamura; Nobutaka Mukumoto; Yoko Goto; Yoshitomo Ishihara; Manabu Nakata; Naozo Sugimoto; Takashi Mizowaki
Journal:  J Appl Clin Med Phys       Date:  2019-09-20       Impact factor: 2.102

10.  Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data.

Authors:  Kai Joachim Borm; Markus Oechsner; Moritz Wiegandt; Andreas Hofmeister; Stephanie E Combs; Marciana Nona Duma
Journal:  BMC Cancer       Date:  2018-07-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.